HOPE FUNDS FOR CANCER RESEARCH (EIN 205799367) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

Tracy Wilson Kooyman

Phone

4018473286

Tax Period

2025-01-01 to 2025-12-31

HOPE FUNDS FOR CANCER RESEARCH, founded in 2006, is a small nonprofit in the Medical Research sector that reported $995K in total revenue in fiscal year 2025. Revenue surged 91% from the prior year, signaling strong growth momentum. The organization ran a surplus of $179K, a strong 18% operating margin.

Mission

The mission of Hope Funds for Cancer Research is to encourage investigation of innovative cancer treatment and detection for the most difficult to treat and understudied cancers. The organization supports scientific and medical research programs relating to both cancer care and prevention.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $1,023,420

Program Service Revenue $0

Investment Income $33,248

Other Revenue $-61,226

TOTAL REVENUE $995,442

Expense Breakdown

Grants Paid $659,248

Salaries & Benefits $0

Fundraising Expenses $47,924

Program Expenses $714,211

Other Expenses $157,234

TOTAL EXPENSES $816,482

Year-over-Year Comparison

	2025	2024	Change
Revenue	$995,442	$520,106	+0.9%
Expenses	$816,482	$523,348	+0.6%
Net Income	$178,960	$-3,242	-56.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Bryan Williams	Trustee	0.50	Director	$0	$0	$0
Cayce Beam	Trustee	0.50	Director	$0	$0	$0
Katherine Dean	Trustee	0.50	Director	$0	$0	$0
Leah Rush Cann	Trustee	0.50	Director	$0	$0	$0
Nicholas DiLoreto	Trustee	0.50	Director	$0	$0	$0
Elizabeth Griffin	Trustee	0.50	Director	$0	$0	$0
Adrian Hobden	Trustee	0.50	Director	$0	$0	$0
Gary Jobson	non-voting Trustee	0.50	Director	$0	$0	$0
Elsa Beyer Krall	Trustee	0.50	Director	$0	$0	$0
Robert Johnson	Trustee	0.50	Director	$0	$0	$0
Charles Holmes	Trustee	0.50	Director	$0	$0	$0
Andrew Mullen	Trustee	0.50	Director	$0	$0	$0
Eugene Kennedy	Trustee	0.50	Director	$0	$0	$0
Bluma Lesch	Trustee	0.50	Director	$0	$0	$0
Juan Manuel Schvartzman	Trustee	0.50	Director	$0	$0	$0
John E Parks	Trustee	0.50	Director	$0	$0	$0
Andrew Robertson	Trustee	0.50	Director	$0	$0	$0
Sohail Tavazoie	Trustee	0.50	Director	$0	$0	$0
John Wells	Trustee	0.50	Director	$0	$0	$0
Gregory Van Schaack	Trustee	0.50	Director	$0	$0	$0
Tracy Wilson	Trustee	0.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$995,442	$816,482	$1,381,790	$178,960
2024	$520,106	$523,348	$1,066,538	$-3,242
2023	$752,347	$516,774	$1,031,079	$235,573
2022	$316,970	$268,996	$890,707	$47,974
2021	$743,798	$840,616	$971,860	$-96,818
2020	$439,679	$550,048	$889,907	$-110,369

HOPE FUNDS FOR CANCER RESEARCH